T1	PROC 44 98	Estudio de fase 3 de extensión a largo plazo y abierto
T2	Date 75 88	a largo plazo
T3	CHEM 102 112	apremilast
#1	AnnotatorNotes T3	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T4	LIVB 116 121	niños
#2	AnnotatorNotes T4	C0008059; Child; Age Group | C0870221; Boys; Age Group
T5	Age 116 121	niños
T6	DISO 126 141	úlceras bucales
#3	AnnotatorNotes T6	C0038363; Aphthous Stomatitis; Disease or Syndrome | C0149745; Oral Ulcer; Disease or Syndrome | C0542250; Ulcer buccal; Disease or Syndrome
T7	DISO 157 177	enfermedad de Behçet
#4	AnnotatorNotes T7	C0004943; Behcet Syndrome; Disease or Syndrome
T8	DISO 184 211	artritis psoriásica juvenil
#5	AnnotatorNotes T8	C0409672
T9	PROC 232 301	Estudio de fase 3 de extensión a largo plazo, multicéntrico y abierto
T10	Date 263 276	a largo plazo
T11	CHEM 305 315	apremilast
#6	AnnotatorNotes T11	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T12	LIVB 319 324	niños
#7	AnnotatorNotes T12	C0008059; Child; Age Group | C0870221; Boys; Age Group
T13	Age 319 324	niños
T14	Age 328 340	2 años o más
T15	DISO 345 360	úlceras bucales
#8	AnnotatorNotes T15	C0038363; Aphthous Stomatitis; Disease or Syndrome | C0149745; Oral Ulcer; Disease or Syndrome | C0542250; Ulcer buccal; Disease or Syndrome
T16	DISO 376 396	enfermedad de Behçet
#9	AnnotatorNotes T16	C0004943; Behcet Syndrome; Disease or Syndrome
T17	Age 402 414	5 años o más
T18	DISO 419 446	artritis psoriásica juvenil
#10	AnnotatorNotes T18	C0409672
T19	DISO 468 470	EB
#11	AnnotatorNotes T19	C0007117; Basal cell carcinoma; Neoplastic Process | C0014121; Bacterial Endocarditis; Disease or Syndrome
T20	DISO 472 507	inflamación en los vasos sanguineos
T21	DISO 524 549	ulceras bucales/genitales
T22	DISO 552 577	lesiones en los ojos/piel
T23	DISO 579 582	AIJ
#12	AnnotatorNotes T23	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T24	DISO 584 617	inflamación de las articulaciones
T25	DISO 622 641	desorden psoriasico
T26	LIVB 655 670	pts pediatricos
T27	Age 659 670	pediatricos
T28	LIVB 695 702	Sujetos
#13	AnnotatorNotes T28	C0681850; Study Subject; Group
T29	DISO 707 727	enfermedad de Behçet
#14	AnnotatorNotes T29	C0004943; Behcet Syndrome; Disease or Syndrome
T30	DISO 730 757	artritis psoriásica juvenil
#15	AnnotatorNotes T30	C0409672
T31	LIVB 797 816	representante legal
T32	LIVB 832 838	sujeto
#16	AnnotatorNotes T32	C0681850; Study Subject; Group
T33	PROC 850 874	consentimiento informado
#17	AnnotatorNotes T33	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T34	LIVB 885 891	sujeto
#18	AnnotatorNotes T34	C0681850; Study Subject; Group
T35	Age 906 921	demasiado joven
T36	PROC 934 958	consentimiento informado
#19	AnnotatorNotes T36	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T37	LIVB 964 970	sujeto
#20	AnnotatorNotes T37	C0681850; Study Subject; Group
T38	PROC 1098 1111	procedimiento
T39	LIVB 1142 1148	sujeto
#21	AnnotatorNotes T39	C0681850; Study Subject; Group
T40	Date 1171 1183	la semana 52
T41	PROC 1193 1204	tratamiento
#22	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	CHEM 1216 1226	apremilast
#23	AnnotatorNotes T42	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T43	CHEM 1334 1341	fármaco
#24	AnnotatorNotes T43	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T44	Neg_cue 1342 1344	no
T45	Negated 1350 1360	disponible
T46	LIVB 1393 1399	sujeto
#25	AnnotatorNotes T46	C0681850; Study Subject; Group
T47	PROC 1425 1448	índice de masa corporal
T48	PROC 1450 1453	IMC
T49	Neg_cue 1485 1487	no
T50	Negated 1492 1515	inferior al percentil 5
T51	PHYS 1531 1542	crecimiento
#26	AnnotatorNotes T51	C0018270; Growth; Organism Function
T52	LIVB 1617 1622	niños
#27	AnnotatorNotes T52	C0008059; Child; Age Group | C0870221; Boys; Age Group
T53	Age 1617 1622	niños
T54	LIVB 1625 1637	adolescentes
#28	AnnotatorNotes T54	C0205653; Adolescent (age group); Age Group
T55	Age 1625 1637	adolescentes
T56	Date 1644 1648	2000
T57	PROC 1670 1684	aleatorización
#29	AnnotatorNotes T57	C0034656; Randomization; Research Activity
T58	LIVB 1692 1698	sujeto
#30	AnnotatorNotes T58	C0681850; Study Subject; Group
T59	PROC 1741 1748	visitas
T60	PROC 1784 1793	protocolo
#31	AnnotatorNotes T60	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T61	LIVB 1823 1829	sujeto
#32	AnnotatorNotes T61	C0681850; Study Subject; Group
T62	PROC 1890 1914	continuar el tratamiento
T63	CHEM 1919 1929	apremilast
#33	AnnotatorNotes T63	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T64	PROC 2028 2035	evaluar
#34	AnnotatorNotes T64	C0220825; Evaluation; Health Care Activity
T65	PROC 2039 2057	riesgo de suicidio
T66	PROC 2073 2079	visita
T67	Date 2083 2095	la semana 52
T68	LIVB 2139 2146	sujetos
#35	AnnotatorNotes T68	C0681850; Study Subject; Group
T69	PROC 2211 2218	Cirugía
#36	AnnotatorNotes T69	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T70	PROC 2238 2252	intervenciones
#37	AnnotatorNotes T70	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T71	LIVB 2274 2280	sujeto
#38	AnnotatorNotes T71	C0681850; Study Subject; Group
T72	Negated 2295 2322	participación en el estudio
T73	LIVB 2327 2349	Mujeres en edad fértil
T74	Age 2338 2349	edad fértil
T75	LIVB 2382 2387	mujer
#39	AnnotatorNotes T75	C0043210; Woman; Population Group | C0242665; wife; Family Group
T76	Age 2404 2415	edad fértil
T77	Age 2425 2434	≥ 12 años
T78	PHYS 2450 2459	menarquia
#40	AnnotatorNotes T78	C0025274; Menarche; Organism Function
T79	Neg_cue 2488 2490	no
T80	PROC 2522 2543	método anticonceptivo
#41	AnnotatorNotes T80	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T81	Negated 2522 2543	método anticonceptivo
T82	PROC 2563 2572	protocolo
#42	AnnotatorNotes T82	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T83	PROC 2624 2635	tratamiento
#43	AnnotatorNotes T83	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T84	Duration 2646 2657	los 30 días
T85	PROC 2675 2689	administración
#44	AnnotatorNotes T85	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T86	CHEM 2713 2738	producto en investigación
T87	LIVB 2743 2750	Mujeres
#45	AnnotatorNotes T87	C0043210; Woman; Population Group | C0242665; wife; Family Group
T88	Duration 2808 2819	los 30 días
T89	CHEM 2854 2879	producto en investigación
T90	LIVB 2884 2906	Mujeres en edad fértil
T91	Age 2895 2906	edad fértil
T92	PROC 2915 2933	prueba de embarazo
#46	AnnotatorNotes T92	C0032976; Pregnancy Tests; Diagnostic Procedure
T93	Date 2953 2964	la semana 0
T94	PROC 2978 3013	prueba de embarazo en suero u orina
T95	LIVB 3055 3061	sujeto
#47	AnnotatorNotes T95	C0681850; Study Subject; Group
T96	DISO 3075 3087	sensibilidad
T97	PROC 3155 3166	tratamiento
#48	AnnotatorNotes T97	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T98	LIVB 3190 3196	sujeto
#49	AnnotatorNotes T98	C0681850; Study Subject; Group
T99	Neg_cue 3197 3199	no
T100	Negated 3205 3260	disponible para completar todas las visitas del estudio
T101	PROC 3241 3248	visitas
T102	PROC 3279 3288	protocolo
#50	AnnotatorNotes T102	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
